137 related articles for article (PubMed ID: 20217508)
21. Characterization of somatostatin receptors and associated signaling pathways in pancreas of R6/2 transgenic mice.
Somvanshi RK; Jhajj A; Heer M; Kumar U
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):359-373. PubMed ID: 29104117
[TBL] [Abstract][Full Text] [Related]
22. Brain glucose sensing and neural regulation of insulin and glucagon secretion.
Thorens B
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():82-8. PubMed ID: 21824260
[TBL] [Abstract][Full Text] [Related]
23. Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes.
Omar-Hmeadi M; Lund PE; Gandasi NR; Tengholm A; Barg S
Nat Commun; 2020 Apr; 11(1):1896. PubMed ID: 32312960
[TBL] [Abstract][Full Text] [Related]
24. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
[TBL] [Abstract][Full Text] [Related]
25. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.
Quesada I; Tudurí E; Ripoll C; Nadal A
J Endocrinol; 2008 Oct; 199(1):5-19. PubMed ID: 18669612
[TBL] [Abstract][Full Text] [Related]
26. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
[TBL] [Abstract][Full Text] [Related]
27. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.
Gromada J; Franklin I; Wollheim CB
Endocr Rev; 2007 Feb; 28(1):84-116. PubMed ID: 17261637
[TBL] [Abstract][Full Text] [Related]
28. α-Cells are dispensable in postnatal morphogenesis and maturation of mouse pancreatic islets.
Shiota C; Prasadan K; Guo P; El-Gohary Y; Wiersch J; Xiao X; Esni F; Gittes GK
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E1030-40. PubMed ID: 23982158
[TBL] [Abstract][Full Text] [Related]
29. Glucagon antagonism as a potential therapeutic target in type 2 diabetes.
Bagger JI; Knop FK; Holst JJ; Vilsbøll T
Diabetes Obes Metab; 2011 Nov; 13(11):965-71. PubMed ID: 21615669
[TBL] [Abstract][Full Text] [Related]
30. The role of dysregulated glucagon secretion in type 2 diabetes.
D'Alessio D
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
[TBL] [Abstract][Full Text] [Related]
31. Glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis.
Ye L; Robertson MA; Hesselson D; Stainier DY; Anderson RM
Development; 2015 Apr; 142(8):1407-17. PubMed ID: 25852199
[TBL] [Abstract][Full Text] [Related]
32. Partial ablation of leptin signaling in mouse pancreatic α-cells does not alter either glucose or lipid homeostasis.
Tudurí E; Denroche HC; Kara JA; Asadi A; Fox JK; Kieffer TJ
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E748-55. PubMed ID: 24473435
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin--clinical implications.
Ciba Found Symp; 1976; 41():313-50. PubMed ID: 780078
[No Abstract] [Full Text] [Related]
34. EphA4 Receptor Forward Signaling Inhibits Glucagon Secretion From α-Cells.
Hutchens T; Piston DW
Diabetes; 2015 Nov; 64(11):3839-51. PubMed ID: 26251403
[TBL] [Abstract][Full Text] [Related]
35. The physiology of glucagon.
Taborsky GJ
J Diabetes Sci Technol; 2010 Nov; 4(6):1338-44. PubMed ID: 21129328
[TBL] [Abstract][Full Text] [Related]
36. Role of glucagon in the pathogenesis of diabetes: the status of the controversy.
Unger RH
Metabolism; 1978 Nov; 27(11):1691-709. PubMed ID: 360007
[TBL] [Abstract][Full Text] [Related]
37. Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point.
Rodriguez-Diaz R; Molano RD; Weitz JR; Abdulreda MH; Berman DM; Leibiger B; Leibiger IB; Kenyon NS; Ricordi C; Pileggi A; Caicedo A; Berggren PO
Cell Metab; 2018 Mar; 27(3):549-558.e4. PubMed ID: 29514065
[TBL] [Abstract][Full Text] [Related]
38. Glucagon, a key factor in the pathophysiology of type 2 diabetes.
Girard J
Biochimie; 2017 Dec; 143():33-36. PubMed ID: 29024725
[TBL] [Abstract][Full Text] [Related]
39. Changes in pancreatic somatostatin content in spontaneously diabetic mice, as determined by radioimmunoassay and immunohistochemical methods.
Makino H; Matsushima Y; Kanatsuka A; Yamamoto M; Kumagai A; Nishimura M
Endocrinology; 1979 Jan; 104(1):243-7. PubMed ID: 376284
[TBL] [Abstract][Full Text] [Related]
40. Insulin as a physiological modulator of glucagon secretion.
Bansal P; Wang Q
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E751-61. PubMed ID: 18647881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
